Articles tagged with "exoskeleton"
Wandercraft raises $75M to scale exoskeletons, humanoids
Wandercraft, a French robotics company, has secured $75 million in Series D funding to advance the commercialization and scaling of its innovative exoskeleton and humanoid robot technologies. The funding will support the launch of Eve, a self-balancing personal exoskeleton designed to provide upright motion and walking independence for individuals with severe mobility impairments, with commercialization targeted as early as 2026. Additionally, Wandercraft aims to expand clinical adoption of its rehabilitation system Atalante X and develop Calvin-40, an industrial-grade humanoid robot intended for physically demanding tasks. The company’s technology leverages AI refined through extensive simulations and real-world use, enhancing natural walking motion and mobility for users. Wandercraft is conducting clinical trials for Eve at the James J. Peters VA Medical Center in New York and will soon start another at the Kessler Institute for Rehabilitation in New Jersey, focusing on safety and effectiveness for spinal cord injury patients. A notable milestone was achieved when Kevin Piette
roboticsexoskeletonhumanoid-robotsAI-powered-roboticsrehabilitation-technologymobility-aidsindustrial-robotsWandercraft unveils Calvin, new industrial humanoid, and Renault partnership - The Robot Report
Wandercraft, a French robotics company founded in 2012 with a mission to aid people with severe mobility impairments, has unveiled its first humanoid robot named Calvin. Developed in just 40 days using technology from its exoskeleton products, Calvin is designed primarily for industrial applications. This launch coincides with Renault Group’s minority investment in Wandercraft, aimed at advancing Calvin as a next-generation industrial robot to alleviate workers from physically demanding tasks, improve ergonomics, and boost productivity. Renault will also support commercialization efforts by leveraging its expertise in cost reduction and scaling, facilitating broader market access for Wandercraft’s robotics, including its new exoskeleton, Eve. Wandercraft’s flagship product, the Atalante X exoskeleton, is a self-stabilizing device used in nearly 100 rehabilitation centers worldwide, enabling patients with spinal cord injuries and stroke to walk and relearn natural motion. It features ActiveBalance mode and 12 degrees of freedom for hips, knees, and ankles, offering benefits for both patients and therapists. The device has FDA clearance and CE marking for various conditions. Building on this success, Wandercraft recently introduced a Personal Exoskeleton prototype designed for everyday use in home and community settings, currently undergoing clinical trials. This system also features a fully powered lower body and dynamic walking control, aiming to enhance personal mobility outside clinical environments.
roboticshumanoid-robotexoskeletonindustrial-automationmobility-assistancerehabilitation-technologyRenault-partnershipNVIDIA accepts Ekso Bionics into its Connect program - The Robot Report
robotexoskeletonmobilityartificial-intelligencerehabilitationhuman-enhancementmedical-technology